InnovAge
INNV
#6658
Rank
NZ$1.18 B
Marketcap
NZ$8.71
Share price
-2.33%
Change (1 day)
5.33%
Change (1 year)

Revenue for InnovAge (INNV)

Revenue in 2025 (TTM): NZ$1.52 Billion

According to InnovAge's latest financial reports the company's current revenue (TTM ) is NZ$1.53 Billion. In 2024 the company made a revenue of NZ$1.43 Billion an increase over the revenue in the year 2023 that were of NZ$1.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for InnovAge from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$1.52 B6.7%
2024 NZ$1.43 B25.48%
2023 NZ$1.13 B5.04%
2022 NZ$1.08 B9.58%
2021 NZ$0.99 B17.68%
2020 NZ$0.84 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AcelRx Pharmaceuticals
ACRX
NZ$1.12 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
NZ$6.31 B 311.95%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Cocrystal Pharma
COCP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$111.27 B 7,160.96%๐Ÿ‡บ๐Ÿ‡ธ USA